Charles R. Kummeth - Aug 5, 2023 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Chief Executive Officer, Director
Signature
/s/ Andrew Nick, as Attorney-in-Fact pursuant to Power of Attorney previously filed.
Stock symbol
TECH
Transactions as of
Aug 5, 2023
Transactions value $
-$2,626,318
Form type
4
Date filed
8/8/2023, 05:31 PM
Previous filing
Jul 25, 2023
Next filing
Aug 11, 2023
SEC
View on sec.gov

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Restricted Stock Units Options Exercise $0 -51.5K -100% $0.00* 0 Aug 5, 2023 Common Stock 51.5K Direct F3, F4
holding TECH Stock Options (Right to Buy) 779K Aug 5, 2023 Common Stock 779K $31.26 Direct F2
holding TECH Stock Options (Right to Buy) 361K Aug 5, 2023 Common Stock 361K $44.33 Direct F2
holding TECH Stock Options (Right to Buy) 241K Aug 5, 2023 Common Stock 241K $44.33 Direct F2
holding TECH Stock Options (Right to Buy) 343K Aug 5, 2023 Common Stock 343K $47.60 Direct F2
holding TECH Stock Options (Right to Buy) 229K Aug 5, 2023 Common Stock 229K $47.60 Direct F2
holding TECH Stock Options (Right to Buy) 66.6K Aug 5, 2023 Common Stock 66.6K $66.97 Direct F2
holding TECH Stock Options (Right to Buy) 300K Aug 5, 2023 Common Stock 300K $66.97 Direct F2
holding TECH Restricted Stock Units 52.9K Aug 5, 2023 Common Stock 52.9K Direct F3, F5
holding TECH Stock Options (Right to Buy) 153K Aug 5, 2023 Common Stock 153K $66.97 Direct F6
holding TECH Restricted Stock Units 32.1K Aug 5, 2023 Common Stock 32.1K Direct F3, F7
holding TECH Stock Options (Right to Buy) 125K Aug 5, 2023 Common Stock 125K $120.46 Direct F7
holding TECH Stock Options (Right to Buy) 83.5K Aug 5, 2023 Common Stock 83.5K $120.46 Direct F8
holding TECH Stock Options (Right to Buy) 600K Aug 5, 2023 Common Stock 600K $94.52 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 7,128 shares of restricted stock for which the risk of forfeiture will lapse on August 6, 2024.
F2 Fully exercisable.
F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F4 On 8/5/2023, the Board of Directors certified vesting of 51,516 performance RSUs.
F5 17,632 shares vest on each of 8/15/2023 and 8/15/2025, and 17,636 shares vest on 8/15/2024.
F6 Options to purchase 38,292 shares vest on 8/5/21 and options to purchase 38,296 shares vest on each of 8/5/22, 8/5/23 and 8/5/24.
F7 Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8 Options to purchase 20,876 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.
F9 600,000 options vest in full or in part on 7/1/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).